In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
Primary Purpose
Dental Caries
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Enamel Pro
Duraphat
Vanish
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Dental Caries
Eligibility Criteria
Inclusion Criteria:
- All subjects between 18-65 years of age and do not fall under any of the exclusion criteria
Exclusion Criteria:
- Subjects with less than 20 teeth
- Subjects with significant untreated disease to include gum disease, extensive decay, or the need for pre-medication prior to dental treatment
- Pregnant or lactating women
- Subjects with a history of allergy to materials to be used in the study
- Subjects unable to produce adequate saliva for sampling
- Subjects deemed low risk for dental caries (no history of restorative work or presence of caries lesions)
- Subjects unable to be available for all 4 cycles of the study
Sites / Locations
- University of Michigan School of Dentistry
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
Enamel Pro
Duraphat
Vanish
Placebo
Arm Description
Varnish containing 5%NaF
Varnish containing 5%NaF
Varnish containing 5%NaF
Bland varnish containing no NaF
Outcomes
Primary Outcome Measures
Fluoride Concentration and Release
Fluoride release as measured by concentration of fluoride available in the oral cavity at different time periods after the application of 5% NaF varnish and placebo as measured in unstimulated human saliva
Secondary Outcome Measures
Full Information
NCT ID
NCT01629290
First Posted
June 10, 2012
Last Updated
April 9, 2017
Sponsor
University of Michigan
Collaborators
Delta Dental Fund of Michigan
1. Study Identification
Unique Protocol Identification Number
NCT01629290
Brief Title
In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
Official Title
In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
Delta Dental Fund of Michigan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.
Detailed Description
This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. Subjects will be recruited at the University of Michigan School of Dentistry and will participate in a 15 minute clinical session at the beginning of each study arm, followed by 6 saliva collection recalls. During these sessions a fluoride varnish or placebo will be applied to their teeth, and subsequent salivary samples will be taken 1 hour, 4 hours, 6 hours, 24 hours, and 48 hours after the application. All subjects will receive 3 commercially available varnishes, and a placebo varnish. Between applications there will be a minimum of 2 weeks wash-out period. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.
Specific Aims
Determine the concentration of fluoride available in the oral cavity at different time periods after the application of three different 5% NaF varnishes as measured in unstimulated human saliva.
Compare the different patterns of fluoride release from each of the varnishes by comparing the fluoride concentration in saliva at corresponding time periods .
Evaluate the validity of an in vitro model used to measure fluoride release from varnishes.
Percentage difference in fluoride release between the in vivo and in vitro data obtained from the same products will be compared. Because the comparison of different patterns of fluoride release from the varnishes is accomplished by analyzing the fluoride available concentration levels, it was an error to list that secondary aim as a secondary - or indeed any sort of outcome measure. The outcome measure data for "patterns of fluoride release" is exactly that which has been fully disclosed in the Primary Outcome Measure data tables. Therefore the secondary outcome measure previously listed: Compare the different patterns of fluoride release from each of the varnishes, which was really never properly an outcome measure, but an aim, has been deleted, with no loss of data transparency.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Enamel Pro
Arm Type
Active Comparator
Arm Description
Varnish containing 5%NaF
Arm Title
Duraphat
Arm Type
Active Comparator
Arm Description
Varnish containing 5%NaF
Arm Title
Vanish
Arm Type
Active Comparator
Arm Description
Varnish containing 5%NaF
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Bland varnish containing no NaF
Intervention Type
Device
Intervention Name(s)
Enamel Pro
Other Intervention Name(s)
Varnish
Intervention Description
Varnish treatment containing 5% NaF
Intervention Type
Device
Intervention Name(s)
Duraphat
Other Intervention Name(s)
Varnish
Intervention Description
Varnish treatment containing 5% NaF
Intervention Type
Device
Intervention Name(s)
Vanish
Other Intervention Name(s)
Varnish
Intervention Description
Varnish treatment containing 5% NaF
Intervention Type
Device
Intervention Name(s)
Placebo
Other Intervention Name(s)
Bland varnish
Intervention Description
Bland varnish containing no NaF
Primary Outcome Measure Information:
Title
Fluoride Concentration and Release
Description
Fluoride release as measured by concentration of fluoride available in the oral cavity at different time periods after the application of 5% NaF varnish and placebo as measured in unstimulated human saliva
Time Frame
Baseline, 1 hr, 4 hrs, 6 hrs, 26 hrs and 50 hrs
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All subjects between 18-65 years of age and do not fall under any of the exclusion criteria
Exclusion Criteria:
Subjects with less than 20 teeth
Subjects with significant untreated disease to include gum disease, extensive decay, or the need for pre-medication prior to dental treatment
Pregnant or lactating women
Subjects with a history of allergy to materials to be used in the study
Subjects unable to produce adequate saliva for sampling
Subjects deemed low risk for dental caries (no history of restorative work or presence of caries lesions)
Subjects unable to be available for all 4 cycles of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Yaman, DDS, MS
Organizational Affiliation
University of Michigan
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Gisele Neiva, DDS, MS
Organizational Affiliation
University of Michigan School of Dentsitry
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Joseph Dennison, DDS, MS
Organizational Affiliation
University of Michigan
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Carlos Gonzalez, DDS,MSD,PhD
Organizational Affiliation
University of Michigan
Official's Role
Study Director
Facility Information:
Facility Name
University of Michigan School of Dentistry
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29614502
Citation
Downey D, Dennison J, Eckert GJ, Flannagan SE, Neiva GF, Yaman P, Gonzalez-Cabezas C. Fluoride Levels in Unstimulated Whole Saliva following Clinical Application of Different 5% NaF Varnishes. Caries Res. 2018;52(6):431-438. doi: 10.1159/000485981. Epub 2018 Apr 3.
Results Reference
derived
Learn more about this trial
In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
We'll reach out to this number within 24 hrs